Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
about
A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques.Estimation of amyloid distribution by [F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
P2860
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Performance of [18F]flutemetam ...... gnosis of Alzheimer's disease.
@en
type
label
Performance of [18F]flutemetam ...... gnosis of Alzheimer's disease.
@en
prefLabel
Performance of [18F]flutemetam ...... gnosis of Alzheimer's disease.
@en
P2093
P2860
P1476
Performance of [18F]flutemetam ...... agnosis of Alzheimer's disease
@en
P2093
Adam S Fleisher
Adrian P L Smith
Andrea Bozoki
Arvinder Hunjan
Carl H Sadowsky
Christopher J Buckley
Craig Curtis
Gill Farrar
P2860
P356
10.1016/J.DADM.2017.06.001
P577
2017-07-01T00:00:00Z